• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

代谢相关脂肪性肝病患者健康生活方式与全因和特定原因死亡率的相关性:来自 DFTJ 队列的研究结果。

Association of healthy lifestyles with risk of all-cause and cause-specific mortality among individuals with metabolic dysfunction-associated steatotic liver disease: results from the DFTJ cohort.

机构信息

Department of Occupational and Environmental Health, State Key Laboratory of Environmental Health (Incubating), School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

出版信息

Ann Med. 2024 Dec;56(1):2398724. doi: 10.1080/07853890.2024.2398724. Epub 2024 Sep 9.

DOI:10.1080/07853890.2024.2398724
PMID:39247937
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11385647/
Abstract

AIM

To examine the associations of healthy lifestyles with risk of all-cause and cause-specific mortality among adults with metabolic dysfunction-associated steatotic liver disease (MASLD), and whether the association was mediated by systemic immune-inflammatory biomarkers (SIIBs).

METHODS

The study included 10,347 subjects with MASLD, who were enrolled in the Dongfeng-Tongji cohort study. The healthy lifestyles referred to non-smoking, being physically active (≥7.5 metabolic equivalents-hours/week), low-risk alcohol consumption (1-14 g/day for women and 1-28 g/day for men), and optimal sleep duration (≥6 to ≤8 h/day). Cox proportional hazard models were used to examine the relationship between each lifestyle and SIIBs with the risk of all-cause and cause-specific mortality. A mediation analysis was conducted to investigate the role of SIIBs on the association between healthy lifestyles and mortality.

RESULTS

There were 418 MASLD subjects dead till the follow-up of 2018, including 259 deaths from cardiovascular disease (CVD). Compared to MASLD participants with 0-1 healthy lifestyle score (HLS), those with 3-4 HLS had the lowest risk of all-cause mortality [hazard ratio (HR), 0.46; 95% CI, (0.36-0.60)], and CVD mortality [HR (95%CI), 0.41 (0.29-0.58)]. Mediation analyses indicated that SIIBs mediated the association between healthy lifestyles and mortality, with proportions ranging from 2.5% to 6.1%.

CONCLUSIONS

These findings suggest that adherence to healthy lifestyles can significantly reduce mortality for MASLD patients, and the decreased SIIBs may partially explain the protection mechanism of healthy lifestyles.

摘要

目的

探讨代谢相关脂肪性肝病(MASLD)患者健康生活方式与全因和特定原因死亡率的相关性,以及这种相关性是否由系统性免疫炎症生物标志物(SIIBs)介导。

方法

该研究纳入了 10347 名 MASLD 患者,他们均来自东风-同济队列研究。健康生活方式包括不吸烟、身体活跃(每周≥7.5 代谢当量小时)、低风险饮酒(女性 1-14g/天,男性 1-28g/天)和最佳睡眠时间(6-8 小时/天)。采用 Cox 比例风险模型分析每种生活方式与 SIIBs 与全因和特定原因死亡率的关系。采用中介分析探讨 SIIBs 在健康生活方式与死亡率之间的关联中的作用。

结果

在 2018 年的随访中,共有 418 名 MASLD 患者死亡,其中 259 人死于心血管疾病(CVD)。与健康生活方式评分(HLS)为 0-1 的 MASLD 患者相比,HLS 为 3-4 的患者全因死亡率最低[风险比(HR)为 0.46(95%CI,0.36-0.60)],CVD 死亡率也最低[HR(95%CI)为 0.41(0.29-0.58)]。中介分析表明,SIIBs 介导了健康生活方式与死亡率之间的关联,其占比范围为 2.5%-6.1%。

结论

这些发现表明,遵循健康的生活方式可以显著降低 MASLD 患者的死亡率,而 SIIBs 的降低可能部分解释了健康生活方式的保护机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e5d/11385647/41f5647b8d29/IANN_A_2398724_F0001_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e5d/11385647/41f5647b8d29/IANN_A_2398724_F0001_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e5d/11385647/41f5647b8d29/IANN_A_2398724_F0001_B.jpg

相似文献

1
Association of healthy lifestyles with risk of all-cause and cause-specific mortality among individuals with metabolic dysfunction-associated steatotic liver disease: results from the DFTJ cohort.代谢相关脂肪性肝病患者健康生活方式与全因和特定原因死亡率的相关性:来自 DFTJ 队列的研究结果。
Ann Med. 2024 Dec;56(1):2398724. doi: 10.1080/07853890.2024.2398724. Epub 2024 Sep 9.
2
Adherence to a healthy lifestyle including sleep and sedentary behaviors and risk of metabolic dysfunction-associated steatotic liver disease in Chinese adults.在中国成年人中,坚持健康的生活方式,包括睡眠和久坐行为,与代谢功能障碍相关的脂肪性肝病的风险有关。
Prev Med. 2024 Jul;184:107971. doi: 10.1016/j.ypmed.2024.107971. Epub 2024 Apr 23.
3
Prognostic effect of triglyceride glucose-related parameters on all-cause and cardiovascular mortality in the United States adults with metabolic dysfunction-associated steatotic liver disease.甘油三酯葡萄糖相关参数对美国代谢功能障碍相关脂肪性肝病患者全因和心血管死亡率的预后影响。
Cardiovasc Diabetol. 2024 Jun 1;23(1):188. doi: 10.1186/s12933-024-02287-y.
4
Association of Depression With All-Cause and Cardiovascular Disease Mortality Among Adults in China.中国成年人抑郁与全因和心血管疾病死亡率的关联。
JAMA Netw Open. 2020 Feb 5;3(2):e1921043. doi: 10.1001/jamanetworkopen.2019.21043.
5
Association between Lifestyle Modification and All-Cause, Cardiovascular, and Premature Mortality in Individuals with Non-Alcoholic Fatty Liver Disease.生活方式改变与非酒精性脂肪性肝病患者全因、心血管和过早死亡的关系。
Nutrients. 2024 Jun 28;16(13):2063. doi: 10.3390/nu16132063.
6
Association between triglyceride-glucose related indices and mortality among individuals with non-alcoholic fatty liver disease or metabolic dysfunction-associated steatotic liver disease.甘油三酯-葡萄糖相关指标与非酒精性脂肪性肝病或代谢相关脂肪性肝病患者死亡的相关性。
Cardiovasc Diabetol. 2024 Jul 4;23(1):232. doi: 10.1186/s12933-024-02343-7.
7
Estimated pulse wave velocity in metabolic dysfunction-associated steatotic liver disease and all-cause/cause-specific mortality.代谢相关脂肪性肝病患者脉搏波速度与全因/死因特异性死亡率的关系。
J Gastroenterol Hepatol. 2024 Sep;39(9):1950-1956. doi: 10.1111/jgh.16608. Epub 2024 May 13.
8
Steatotic liver disease-associated all-cause/cause-specific mortality in the United States.美国脂肪变性肝病相关全因/病因特异性死亡率。
Aliment Pharmacol Ther. 2024 Jul;60(1):33-42. doi: 10.1111/apt.18011. Epub 2024 Apr 22.
9
Hepatic steatosis, metabolic dysfunction and risk of mortality: findings from a multinational prospective cohort study.肝脂肪变性、代谢功能障碍与死亡率风险:一项多国前瞻性队列研究的结果。
BMC Med. 2024 Jun 3;22(1):221. doi: 10.1186/s12916-024-03366-3.
10
Associations of healthy lifestyle and socioeconomic status with mortality and incident cardiovascular disease: two prospective cohort studies.健康生活方式和社会经济地位与死亡率和心血管疾病发病的关联:两项前瞻性队列研究。
BMJ. 2021 Apr 14;373:n604. doi: 10.1136/bmj.n604.

本文引用的文献

1
Associations of arsenic exposure and arsenic metabolism with the risk of non-alcoholic fatty liver disease.砷暴露和砷代谢与非酒精性脂肪性肝病风险的关联。
Int J Hyg Environ Health. 2024 Apr;257:114342. doi: 10.1016/j.ijheh.2024.114342. Epub 2024 Feb 23.
2
Clinical profiles and mortality rates are similar for metabolic dysfunction-associated steatotic liver disease and non-alcoholic fatty liver disease.代谢相关脂肪性肝病和非酒精性脂肪性肝病的临床特征和病死率相似。
J Hepatol. 2024 May;80(5):694-701. doi: 10.1016/j.jhep.2024.01.014. Epub 2024 Jan 27.
3
MASLD: a systemic metabolic disorder with cardiovascular and malignant complications.
代谢相关脂肪性肝病:一种伴有心血管和恶性并发症的全身性代谢紊乱疾病。
Gut. 2024 Mar 7;73(4):691-702. doi: 10.1136/gutjnl-2023-330595.
4
Associations of Combined Lifestyle Factors with MAFLD and the Specific Subtypes in Middle-Aged and Elderly Adults: The Dongfeng-Tongji Cohort Study.联合生活方式因素与中老年人群 MAFLD 及其特定亚型的相关性:东风-同济队列研究。
Nutrients. 2023 Oct 28;15(21):4588. doi: 10.3390/nu15214588.
5
MASLD vs. NAFLD: A better definition for children with obesity at higher risk of kidney damage.代谢功能障碍相关脂肪性肝病与非酒精性脂肪性肝病:对有更高肾脏损伤风险的肥胖儿童的更好定义。
J Hepatol. 2024 Feb;80(2):e87-e89. doi: 10.1016/j.jhep.2023.10.021. Epub 2023 Oct 27.
6
Changing from NAFLD to MASLD: The new definition can more accurately identify individuals at higher risk for diabetes.从非酒精性脂肪性肝病转变为代谢功能障碍相关脂肪性肝病:新定义能够更准确地识别出糖尿病风险较高的个体。
J Hepatol. 2024 Feb;80(2):e85-e87. doi: 10.1016/j.jhep.2023.09.035. Epub 2023 Oct 10.
7
99% of patients with NAFLD meet MASLD criteria and natural history is therefore identical.99%的非酒精性脂肪性肝病患者符合代谢功能障碍相关脂肪性肝病标准,因此其自然病史相同。
J Hepatol. 2024 Feb;80(2):e76-e77. doi: 10.1016/j.jhep.2023.08.026. Epub 2023 Sep 9.
8
Metabolic dysfunction-associated steatotic liver disease (MASLD) definition is better than MAFLD criteria for lean patients with NAFLD.对于非酒精性脂肪性肝病(NAFLD)的瘦患者,代谢功能障碍相关脂肪性肝病(MASLD)的定义优于代谢功能障碍相关脂肪性肝病(MAFLD)标准。
J Hepatol. 2024 Feb;80(2):e61-e62. doi: 10.1016/j.jhep.2023.07.031. Epub 2023 Aug 7.
9
Aggregate Index of Systemic Inflammation (AISI), Disease Severity, and Mortality in COVID-19: A Systematic Review and Meta-Analysis.新冠病毒肺炎中全身炎症综合指数(AISI)、疾病严重程度和死亡率:一项系统评价与荟萃分析
J Clin Med. 2023 Jul 10;12(14):4584. doi: 10.3390/jcm12144584.
10
A healthy lifestyle, Life's Essential 8 scores and new-onset severe NAFLD: A prospective analysis in UK Biobank.健康的生活方式、“生命必需的 8 项指标”评分与新发严重非酒精性脂肪性肝病:英国生物库的前瞻性分析。
Metabolism. 2023 Sep;146:155643. doi: 10.1016/j.metabol.2023.155643. Epub 2023 Jun 26.